• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化的病理生理学。

Pathophysiology of Atherosclerosis.

机构信息

Department of Biochemistry and Molecular Biology, Universidad del País Vasco UPV/EHU, 48940 Leioa, Bizkaia, Spain.

Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa, Bizkaia, Spain.

出版信息

Int J Mol Sci. 2022 Mar 20;23(6):3346. doi: 10.3390/ijms23063346.

DOI:10.3390/ijms23063346
PMID:35328769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8954705/
Abstract

Atherosclerosis is the main risk factor for cardiovascular disease (CVD), which is the leading cause of mortality worldwide. Atherosclerosis is initiated by endothelium activation and, followed by a cascade of events (accumulation of lipids, fibrous elements, and calcification), triggers the vessel narrowing and activation of inflammatory pathways. The resultant atheroma plaque, along with these processes, results in cardiovascular complications. This review focuses on the different stages of atherosclerosis development, ranging from endothelial dysfunction to plaque rupture. In addition, the post-transcriptional regulation and modulation of atheroma plaque by microRNAs and lncRNAs, the role of microbiota, and the importance of sex as a crucial risk factor in atherosclerosis are covered here in order to provide a global view of the disease.

摘要

动脉粥样硬化是心血管疾病(CVD)的主要危险因素,是全球范围内导致死亡的主要原因。动脉粥样硬化由内皮细胞激活引发,随后一系列事件(脂质、纤维成分和钙化的积累)引发血管狭窄和炎症途径的激活。由此产生的动脉粥样硬化斑块,以及这些过程,导致心血管并发症。本综述重点介绍了动脉粥样硬化发展的不同阶段,从内皮功能障碍到斑块破裂。此外,还介绍了 microRNAs 和 lncRNAs 对动脉粥样硬化斑块的转录后调控和调节、微生物组的作用以及性别作为动脉粥样硬化的关键风险因素的重要性,以便全面了解该疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/332ae6f51b27/ijms-23-03346-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/d9839d921ea0/ijms-23-03346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/f01602cae46e/ijms-23-03346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/9e659bb8536b/ijms-23-03346-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/332ae6f51b27/ijms-23-03346-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/d9839d921ea0/ijms-23-03346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/f01602cae46e/ijms-23-03346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/9e659bb8536b/ijms-23-03346-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/8954705/332ae6f51b27/ijms-23-03346-g004.jpg

相似文献

1
Pathophysiology of Atherosclerosis.动脉粥样硬化的病理生理学。
Int J Mol Sci. 2022 Mar 20;23(6):3346. doi: 10.3390/ijms23063346.
2
The role of metabolic disorders in the development of atherosclerosis.代谢紊乱在动脉粥样硬化发展中的作用。
Cell Mol Biol (Noisy-le-grand). 2024 Oct 8;70(9):148-155. doi: 10.14715/cmb/2024.70.9.21.
3
Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.血管生成:血管源学说——动脉粥样硬化发生发展的关键因素及心血管疾病治疗的潜在靶点。
Front Immunol. 2018 Apr 17;9:706. doi: 10.3389/fimmu.2018.00706. eCollection 2018.
4
Microcalcifications, Their Genesis, Growth, and Biomechanical Stability in Fibrous Cap Rupture.微钙化,其在纤维帽破裂中的发生、生长和生物力学稳定性。
Adv Exp Med Biol. 2018;1097:129-155. doi: 10.1007/978-3-319-96445-4_7.
5
Thrombosis formation on atherosclerotic lesions and plaque rupture.动脉粥样硬化病变和斑块破裂导致血栓形成。
J Intern Med. 2014 Dec;276(6):618-32. doi: 10.1111/joim.12296. Epub 2014 Sep 25.
6
Inflammation in atherosclerosis: a cause or a result of vascular disorders?动脉粥样硬化中的炎症:是血管紊乱的原因还是结果?
J Cell Mol Med. 2012 Sep;16(9):1978-90. doi: 10.1111/j.1582-4934.2012.01552.x.
7
Extracellular Vesicles in Atherosclerosis: State of the Art.细胞外囊泡在动脉粥样硬化中的研究进展。
Int J Mol Sci. 2023 Dec 27;25(1):388. doi: 10.3390/ijms25010388.
8
From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.从动脉粥样硬化血栓形成的病理生理学到靶向治疗:他汀类药物与阿司匹林联合应用在二级预防中的作用
Pharmacol Ther. 2007 Jan;113(1):184-96. doi: 10.1016/j.pharmthera.2006.08.005. Epub 2006 Sep 15.
9
[Pathology of AtheroThrombosIS (ATIS)].动脉粥样硬化血栓形成(ATIS)的病理学
Drugs. 2010 Nov 1;70 Suppl 1:3-8. doi: 10.2165/00000004-000000000-00000.
10
Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.脂质和斑块内缺氧在动脉粥样硬化新生血管形成中的作用。
Ann Med. 2017 Dec;49(8):661-677. doi: 10.1080/07853890.2017.1366041. Epub 2017 Aug 22.

引用本文的文献

1
Ex Vivo Characterization of Peritoneal Macrophages from Novel ABCA1-LSL and ABCG1-LSL Mice for Macrophage-Specific ABC-Transporter Overexpression.新型ABCA1-LSL和ABCG1-LSL小鼠腹膜巨噬细胞用于巨噬细胞特异性ABC转运蛋白过表达的体外表征
Biology (Basel). 2025 Aug 18;14(8):1073. doi: 10.3390/biology14081073.
2
Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease.慢性丙型肝炎与动脉粥样硬化性和心肌病性心脏病的风险
World J Hepatol. 2025 Aug 27;17(8):108678. doi: 10.4254/wjh.v17.i8.108678.
3
Lipid overload meets S-palmitoylation: a metabolic signalling nexus driving cardiovascular and heart disease.

本文引用的文献

1
Gut Microbiota and Atherosclerosis-Focusing on the Plaque Stability.肠道微生物群与动脉粥样硬化——聚焦斑块稳定性
Front Cardiovasc Med. 2021 Aug 3;8:668532. doi: 10.3389/fcvm.2021.668532. eCollection 2021.
2
The iterative lipid impact on inflammation in atherosclerosis.动脉粥样硬化中脂质对炎症的反复影响。
Curr Opin Lipidol. 2021 Oct 1;32(5):286-292. doi: 10.1097/MOL.0000000000000779.
3
Efferocytosis of vascular cells in cardiovascular disease.血管细胞的噬作用与心血管疾病。
脂质过载与S-棕榈酰化相遇:驱动心血管疾病和心脏病的代谢信号枢纽。
Cell Commun Signal. 2025 Sep 2;23(1):392. doi: 10.1186/s12964-025-02398-3.
4
The Association Between Neutrophil-to-Lymphocyte Ratio, Atherogenic Index of Plasma, and Cardiovascular Disease Incidence.中性粒细胞与淋巴细胞比值、血浆致动脉粥样硬化指数与心血管疾病发病率之间的关联
Mediators Inflamm. 2025 Aug 22;2025:3302911. doi: 10.1155/mi/3302911. eCollection 2025.
5
Nutritional-inflammatory balance assessed by advanced lung cancer inflammation index and its association with all-cause mortality in coronary heart disease : a retrospective cohort study.通过晚期肺癌炎症指数评估的营养-炎症平衡及其与冠心病全因死亡率的关联:一项回顾性队列研究
J Health Popul Nutr. 2025 Aug 31;44(1):317. doi: 10.1186/s41043-025-01063-2.
6
Coronary Artery Disease and Atherosclerosis in Other Vascular Districts: Epidemiology, Risk Factors and Atherosclerotic Plaque Features.冠状动脉疾病与其他血管区域的动脉粥样硬化:流行病学、危险因素及动脉粥样硬化斑块特征
Life (Basel). 2025 Aug 3;15(8):1226. doi: 10.3390/life15081226.
7
Salusins in Atherosclerosis: Dual Roles in Vascular Inflammation and Remodeling.Salusins与动脉粥样硬化:在血管炎症和重塑中的双重作用
Biomedicines. 2025 Aug 15;13(8):1990. doi: 10.3390/biomedicines13081990.
8
Pathophysiological Links Between Inflammatory Bowel Disease and Cardiovascular Disease: The Role of Dysbiosis and Emerging Biomarkers.炎症性肠病与心血管疾病之间的病理生理联系:肠道菌群失调及新型生物标志物的作用
Biomedicines. 2025 Jul 31;13(8):1864. doi: 10.3390/biomedicines13081864.
9
Artesunate Ameliorates SLE Atherosclerosis Through PPARγ-Driven Cholesterol Efflux Restoration and Disruption of Lipid Raft-Organized TLR9/MyD88 Signaling Pathway.青蒿琥酯通过PPARγ驱动的胆固醇流出恢复和破坏脂筏组织的TLR9/MyD88信号通路改善系统性红斑狼疮相关动脉粥样硬化。
Biomolecules. 2025 Jul 25;15(8):1078. doi: 10.3390/biom15081078.
10
Cys-Ala-Gly Peptides and Amphiphilic mPEG-PLGA Polymer Modified ZE21B Magnesium Alloy for Enhanced Anticorrosion and Pro-Endothelialization Potential.用于增强防腐性能和促进内皮化潜力的半胱氨酸-丙氨酸-甘氨酸肽与两亲性甲氧基聚乙二醇-聚乳酸-羟基乙酸共聚物修饰的ZE21B镁合金
ACS Omega. 2025 Aug 5;10(32):36351-36363. doi: 10.1021/acsomega.5c04556. eCollection 2025 Aug 19.
Pharmacol Ther. 2022 Jan;229:107919. doi: 10.1016/j.pharmthera.2021.107919. Epub 2021 Jun 23.
4
Nitric oxide signalling in kidney regulation and cardiometabolic health.一氧化氮信号在肾脏调节和心脏代谢健康中的作用。
Nat Rev Nephrol. 2021 Sep;17(9):575-590. doi: 10.1038/s41581-021-00429-z. Epub 2021 Jun 1.
5
Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages.MERTK 的配体依赖性激酶活性驱动人 iPSC 衍生巨噬细胞的吞噬作用。
Cell Death Dis. 2021 May 25;12(6):538. doi: 10.1038/s41419-021-03770-0.
6
miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches.miR-33 在心脏代谢疾病中的作用:新型动物模型和方法的启示。
EMBO Mol Med. 2021 May 7;13(5):e12606. doi: 10.15252/emmm.202012606. Epub 2021 May 3.
7
The changing landscape of atherosclerosis.动脉粥样硬化的变化格局。
Nature. 2021 Apr;592(7855):524-533. doi: 10.1038/s41586-021-03392-8. Epub 2021 Apr 21.
8
The endocytosis of oxidized LDL via the activation of the angiotensin II type 1 receptor.通过激活1型血管紧张素II受体实现氧化型低密度脂蛋白的内吞作用。
iScience. 2021 Jan 21;24(2):102076. doi: 10.1016/j.isci.2021.102076. eCollection 2021 Feb 19.
9
Microbiota-Mediated Immune Regulation in Atherosclerosis.微生物群介导的动脉粥样硬化中的免疫调节。
Molecules. 2021 Jan 1;26(1):179. doi: 10.3390/molecules26010179.
10
Role of Vascular Smooth Muscle Cell Plasticity and Interactions in Vessel Wall Inflammation.血管平滑肌细胞的可塑性及其相互作用在血管壁炎症中的作用。
Front Immunol. 2020 Nov 26;11:599415. doi: 10.3389/fimmu.2020.599415. eCollection 2020.